跳至主要内容
临床试验/NCT06360627
NCT06360627招募中不适用

Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

University of Zurich2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年2月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
2
主要终点
stable Image Quality in reduced dose scans

研究概览

简要总结

Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • CT SCAN for pulmonary nodule detection/follow up
  • CT SCAN for pneumonia detection/follow up

排除标准

  • BMI over 30

结局指标

主要结局

stable Image Quality in reduced dose scans

时间窗: through study completion, an average of 1 year

Recorded values compared in 2 populations-different contrast agents by using qualitative\&quantitative methods Qualitative:diagnostic certainty, assessability of lung structure/lesions,diagnostic reliability, Quantitative:Assessment of tissue composition,diagnostic performance measurements Attenuation/sealing measurement (HU), signal-to-noise ratio (SNR), contrast-to-noise ratio ,size dimensions of lung structure/lesion in three dimensions in millimeters Tissue composition assessment diagnostic performance measurements (sensitivity, specificity, accuracy) diagnostic confidence: 1-4 Theses measurements will be put in correlation to the scan dose (mSv) per patient, forming two groups with matched BMI (kg/m\^2)

Dose Reduction by new scanner

时间窗: through study completion, an average of 1 year

mSv per exam will be recorded. This value will be put in correlation to weight (Kg), height (cm) and BMI.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验